ÇѸ²´ëÇб³¼º½Éº´¿ø

³ë´ë¿µ ±³¼ö

  • Áø·á°ú Á¤½Å°Ç°­ÀÇÇаú

Àü¹®Áø·áºÐ¾ß

°­¹ÚÁõ ¹× ºÒ¾ÈÀå¾Ö, ½ºÆ®·¹½º, Á¶Çöº´, ¿ì¿ï ¹× Á¶¿ï

ÀüÈ­ ¿¹¾à 033) 240-5000
±³¼ö´Ô»çÁø

(ÁÖ°£) Áø·á½Ã°£Ç¥ (2024-11-18 ~ 2024-11-23)

Áø·á½Ã°£Ç¥
Áø·á½Ã°£ ¿ù È­ ¼ö ¸ñ ±Ý Åä
¿ÀÀü ÈÞÁøÈÞÁø
¿ÀÈÄ ÈÞÁøÈÞÁøÈÞÁø

ÇØ¿Ü ¿¬¼ö Áß (Visiting Professor, Massachusetts General Hospital and HMS) 2024.04.01 ~ 2025.03.31

±³¼ö´Ô »çÁø

±âº»Á¤º¸

ÇзÂ

ÇзÂ

1996.03 ~ 2004.02¿¬¼¼´ëÇб³ ÀÇÇÐ Çлç

2006.09 ~ 2008.08¿¬¼¼´ëÇб³ ÀÇÇÐ ¼®»ç

2009.09 ~ 2014.02¿¬¼¼´ëÇб³ ÀÇÇÐ ¹Ú»ç

°æ·Â

°æ·Â

¼¼ºê¶õ½ºÁ¤½Å°Ç°­º´¿ø ÀÓ»ó°­»ç

¼¼ºê¶õ½ºÁ¤½Å°Ç°­º´¿ø Àӻ󿬱¸Á¶±³¼ö

±¤¸í½ÃÁ¤½Åº¸°Ç¼¾ÅÍ ¼¾ÅÍÀå

Ãáõ½ÃÁßµ¶°ü¸®ÅëÇÕÁö¿ø¼¾ÅÍ ¼¾ÅÍÀå

(Çö)Ãáõ½º¸¶Àϼ¾ÅÍ ¼¾ÅÍÀå (¹ý¹«ºÎ ¼³¸³ ¹üÁËÇÇÇØ Æ®¶ó¿ì¸¶ ÅëÇÕÁö¿ø±â°ü)

ÇÐȸȰµ¿

ÇÐȸȰµ¿

´ëÇѺҾÈÀÇÇÐȸ À繫ÀÌ»ç

Çѱ¹»ý¹°Á¤½ÅÀÇÇÐȸ À繫ÀÌ»ç

´ëÇѳúÀÚ±ØÇÐȸ À繫ÀÌ»ç

´ëÇÑÁ¤½Å¾à¹°ÇÐȸ ÆòÀÌ»ç

´ëÇѳëÀÎÁ¤½ÅÀÇÇÐȸ Æò»ýȸ¿ø

¼ö»óÀÌ·Â

¼ö»óÀÌ·Â

Æú¾á¼¾ ¹Ú»ç ¿¬±¸ Çмú»ó (2022, ´ëÇѽŰæÁ¤½ÅÀÇÇÐȸ)

¹ý¹«ºÎÀå°ü ǥâ (2019, ¹ý¹«ºÎ)

±Û¶ô¼Ò½º¹Ì½ºÅ¬¶óÀÎ Çмú»ó (2018, ´ëÇѽŰæÁ¤½ÅÀÇÇÐȸ)

Best Poster Award (2017, ¾Æ½Ã¾Æ ½Å°æÁ¤½Å¾à¹°ÇÐȸ)

Á¦12ȸ º¸·ÉÀÇ»ç¼öÇʹ®Çлó ±Ý»ó (2016, º¸·ÉÁ¦¾à)

Young Investigator Fellowship Award (2011, ¾Æ½Ã¾Æ ½Å°æÁ¤½Å¾à¹°ÇÐȸ)

New Research Award (2011, ¾Æ½Ã¾Æ ½Å°æÁ¤½Å¾à¹°ÇÐȸ)

ÃÖ¿ì¼ö ³í¹®»ó (2010, ´ëÇÑÁ¤½Å¾à¹°ÇÐȸÃá°èÇÐȸ)

³í¹®

±¹Á¦

1. Park JE, Kang SH, Won SD, Roh D, Kim WH. Assessment Instruments for Disaster Behavioral Health Anxiety and Mood 2015;11(2):91-105

2. Chang JG, Roh D, Kim CH. The Reliability and Validity of the Korean Version of Medication Adherence Rating Scale. Korean J Psychopharmacol 2015;26(2):43-49

3. Yoon S, Kim CH, Lee HB, Roh D. The Effect of Individually Tailored Group Aerobic Exercise in Patients with Chronic Mental Illness. J Korean Assoc Soc Psychiatry. 2014 19(1): 18-26.

4. Chang JG, Roh D, Ahn SK, Cho HS, Kim CH Antipsychotic Polypharmacy in the Treatment of Patients with Related Psychoses at a University Hospital. Korean J Psychopharmacol 2013;24:69-75

5. Chang JG, Roh D, Kim CH. Recent Trends of Antipsychotics Polypharmacy in Schizophrenia. Korean J Psychopharmacol 2013;24:137-146

6. Roh D, Chang JG, Kim CH. Improving Medication Adherence in Patients with Severe Mental Illness. Korean J Psychopharmacol 2012;23:155-165

7. Roh D, Kim CH. The Past, Present and Future Possibility of Long-Acting Injectable Antipsychotics in Korean Patients with Schizophrenia. Korean J Psychopharmacol 2011;22 Suppl:S64-S72

8. Hwang SS, Roh D, Kim CH. Association between the GRIN2B Gene and Age of Onset in Obsessive-Compulsive Disorder. Anxiety and Mood 2011;7(1):34-39

9. Roh D, Kim CH. At Risk State for Psychosis: Related Issues and Future Directions. Korean J Biol Psychiatry 2011;18:203-209

10. Roh D, Park KM, Kim YK, Lee SM, Ryu YH, Kim CH. Abnormal Cerebral Benzodiazepine Receptors Binding Measured with [ 123 I]-Iomazenil SPECT in Panic Disorder. J Korean Neuropsychiatr Assoc 2010;49:235-240

11. Hwang SS, Roh D, Kim CH. The Significance of Affective Problems in Obsessive-Compulsive Disorder. Anxiety and Mood 2010;6(1):10-16

12. Roh D, Kim J, Kim CH. Concept, Diagnostic Criteria and a Future Prospective of Obsessive-Compulsive Disorder Anxiety and Mood 2010;6(2):93-101

13. Roh D, Kim SJ, Kim CH. The Relationship Between Clinical Characteristics and Impulsiveness in Obsessive-Compulsive Disorder. J Korean Neuropsychiatr Assoc 2009;48:336-343

14. Kyung Ryeol Cha, Joon Suk Lim, Junyoung Park, Su-young Lee, Kwanguk Kim, Dae Young Roh, Se-Joo Kim, Min-Seong Koo, and Chan-Hyung Kim, A Validation Study of the Korean-version of Symmetry, Ordering and Arranging Questionnaire. J Korean Neuropsychiatr Assoc 2008;47(3):263-268

±¹³»

1. Á¶Çöº´ ȯÀÚ¿¡¼­ Ç×Á¤½Åº´¾à¹° º´¿ë¿ä¹ýÀÇ ÃÖ±Ù µ¿Çâ (2013, ´ëÇÑÁ¤½Å¾à¹°ÇÐȸÁö)
2. ÁßÁõ Á¤½Å Áúȯ ȯÀÚ¿¡¼­ÀÇ ¾à¹° ¼øÀÀµµ Çâ»ó (2012, ´ëÇÑÁ¤½Å¾à¹°ÇÐȸÁö)
3. Á¤½Åº´ À§Çè»óÅ : °ü·ÃµÈ ¹®Á¦¿Í ÇâÈÄ Àü¸Á (2011, »ý¹°Á¤½ÅÀÇÇÐ)
4. ±¹³» Á¤½ÅºÐ¿­º´ ȯÀÚ¿¡¼­ Ç×Á¤½Åº´¾à¹° Àå±âÁö¼ÓÇü ÁÖ»çÁ¦ÀÇ °ú°Å, ÇöÀç ¹× ÇâÈÄ °¡´É¼º (2011, ´ëÇÑÁ¤½Å¾à¹°ÇÐȸÁö)
5. ±Û·çŸ¸ÞÀÌÆ® ¼ö¿ëü À¯ÀüÀÚ¿Í °­¹ÚÀå¾Ö ¹ßº´ ¿¬·É°úÀÇ °ü·Ã¼º (2011, ´ëÇѺҾÈÀÇÇÐȸÁö)
6. °­¹ÚÀå¾ÖÀÇ °³³ä°ú Áø´Ü±âÁØÀÇ º¯Ãµ°ú ÇâÈÄ ¹æÇâ (2010, ´ëÇѺҾÈÀÇÇÐȸÁö)
7. °­¹ÚÀå¾Ö¿¡¼­ Á¤¼­ ÀÌ»óÀÇ ÀÇ¹Ì (2010, ´ëÇѺҾÈÀÇÇÐȸÁö)
8. [123I]-IomazenilSPECT¸¦ ÀÌ¿ëÇÑ °øȲÀå¾Ö ȯÀÚ¿¡¼­ ´ë³ú º¥Á¶´ÙÀ̾ÆÁ¦ÇÉ ¼ö¿ëü °áÇÕ ÀÌ»ó (2010, ´ëÇѽŰæÁ¤½ÅÀÇÇÐ)